Precision medicine: preliminary results from the Initiative for Molecular Profiling and Advanced Cancer Therapy 2 (IMPACT2) study
Abstract Precision medicine is associated with favorable outcomes in selected patients with cancer. Herein, we report an interim analysis of IMPACT2, an ongoing randomized study evaluating genomic profiling and targeted agents in metastatic cancer. Patients with metastatic cancer underwent tumor gen...
Guardado en:
Autores principales: | Apostolia Maria Tsimberidou, David S. Hong, Siqing Fu, Daniel D. Karp, Sarina Piha-Paul, Merrill S. Kies, Vinod Ravi, Vivek Subbiah, Sunil M. Patel, Shi-Ming Tu, Filip Janku, John Heymach, Amber Johnson, Carrie Cartwright, Li Zhao, Jianhua Zhang, Donald A. Berry, David J. Vining, Andrew Futreal, Vincent A. Miller, Funda Meric-Bernstam |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/33315794ca1f4daf8eba5da8574c8e3f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Associations between the gut microbiome and fatigue in cancer patients
por: Joud Hajjar, et al.
Publicado: (2021) -
Emergence of mTOR mutation as an acquired resistance mechanism to AKT inhibition, and subsequent response to mTORC1/2 inhibition
por: Niamh Coleman, et al.
Publicado: (2021) -
Pembrolizumab in vaginal and vulvar squamous cell carcinoma: a case series from a phase II basket trial
por: Jeffrey A. How, et al.
Publicado: (2021) -
Nanogrid single-nucleus RNA sequencing reveals phenotypic diversity in breast cancer
por: Ruli Gao, et al.
Publicado: (2017) -
Many-Body Electronic Structure of NdNiO_{2} and CaCuO_{2}
por: Jonathan Karp, et al.
Publicado: (2020)